Diastolic blood pressure and hypertension phenotypes: The us food and drug administration has it right

Journal of Clinical Hypertension

Volumn 15, Issue 3, 2013, Pages 145-146

  Giles, Thomas ^a   Sander, Gary E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; EDITORIAL; HEART HEMODYNAMICS; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; TYPE 1 HYPERTENSION; TYPE 2 HYPERTENSION; TYPE 3 HYPERTENSION; VASCULAR RESISTANCE;

BLOOD PRESSURE; HUMANS; HYPERTENSION; PHENOTYPE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84874579746     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12053     Document Type: Editorial

References (4)

1. Giles TD, Berk BC, Black HR, et al. Expanding the definition and classification of hypertension. J Clin Hypertens. 2005;7:505-512.
2. Izzo JL Jr, Giles TD, Matterson BJ. Defining the syndrome of hypertension. In: Izzo JL Jr, Sica DA, Black HR, eds. Hypertension Primer, 4th ed. American Heart Association, Lippincott Williams & Wilkins; 2008: 351-355.
3. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a cooperative study. JAMA. 1977;237:255-261.
4. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1980;140:1280-1285.